Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia

Muscle and Nerve

Volumn 51, Issue 6, 2015, Pages 815-821

  Jordan, Heather ^a   Rechtman, Lindsay ^a   Wagner, Laurie ^a   Kaye, Wendy E ^a  

^a McKing Consulting Corp   (United States)

Author keywords

Amyotrophic lateral sclerosis; Baltimore; Epidemiology; Incidence; Motor neuron disease; Philadelphia; Surveillance

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASIAN; BLACK PERSON; CAUCASIAN; DEATH CERTIFICATE; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; FEMALE; GROUPS BY AGE; HISPANIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROLOGIST; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES; VERY ELDERLY; AGE; AGE DISTRIBUTION; ELECTROMYOGRAPHY; EPIDEMIOLOGICAL MONITORING; REGISTER;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BALTIMORE; ELECTROMYOGRAPHY; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHILADELPHIA; REGISTRIES; SEX FACTORS;

EID: 84929511163     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24488     Document Type: Article

References (31)

1. Gordon PH. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis 2013;4:295-310.
2. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2011;82:623-627.
3. Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 2005;113:1250-1256.
4. Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology 2003;61:750-756.
5. Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, Yost MG, et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med 2005;48:63-77.
6. Fang F, Quinlin P, Ye W, Barber MK, Umbach DM, Sandler DP, et al. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect 2009;117:1387-1392.
7. Beghi E, Logrosino G, Chio A, Hardiman O, Millul A, Mitchell D, et al. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler 2010;11:289-292.
8. Fallis BA, Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds. Amyotroph Lateral Scler 2009;10:95-98.
9. Das K, Nag C, Ghosh M. Familial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis. N Am J Med Sci 2012;4;350-355.
10. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. World Federation of Neurology Research Group on Motor Neuron Diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
11. Hirtz D, Thurman D, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology 2007;68:326-337.
12. Wagner L, Archer NP, Williamson D, et al. Prevalence of amyotrophic lateral sclerosis in Texas, 1998-2003. Texas Med 2012;108:e1.
13. Nelson LM, van den Eeden SK, Tanner CM, Bernstein AL. Incidence of amyotrophic lateral sclerosis in a multiethnic health care organization. Neuroepidemiology 2010;34:276.
14. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 2008;71:1889-1895.
15. Turabelidze G, Zhu B, Scootman M, Malone JL, Horowitz S, Weidinger J, et al. An epidemiological investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. Neurotoxicology 2008;29:81-86.
16. Ragonese P, Cellura E, Aridon P, D'amelio M, Spartaro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amytroph Lateral Scler 2012;13:284-287.
17. Logrosino G, Traynor B, Hardiman O, Chio A, Mitchell D, Swingler R, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81:385-390.
18. Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011. Neuroepidemiology 2014;43:49-56. DOI: 10.1159/000365850.
19. Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health 2012;75:28-30.
20. National Amyotrophic Lateral Sclerosis (ALS) Registry. Centers for Disease Control and Prevention/Agency for Toxic Substance and Disease Registry Web site. http://wwwn.cdc.gov/als. Updated January 17, 2013. Accessed January 20, 2014.
21. AMTRAK. North East Train Routes. AMTRAK Web site. http://www.amtrak.com/northeast-train-routes. Accessed October 30, 2013.
22. State and County QuickFacts. United States Census Bureau/American Factfinder Web site. http://quickfacts.census.gov/qfd/states/32/32003.html. Accessed December 15, 2013.
23. 2010 Census briefs: population distribution and change: 2000 to 2010. United States Census Bureau Web site. http://www.census.gov/prod/cen2010/briefs/c2010br-01.pdf. Accessed December 2013.
24. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. Geneva: World Health Organization. 1992.
25. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. Healthy People 2010 Stat Notes. January 2001:1-10.
26. Microsoft. 2010. Microsoft Excel [computer software]. Redmond, WA: Microsoft.
27. IBM Corp. Released 2010. IBM SPSS Statistics for Windows, Version 19.0. Armonk, NY: IBM Corp.
28. Donaghy C, Clarke J, Patterson C, Kee F, Hardiman O, Patterson V. The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology. Amyotrophic Lateral Sclerosis 2010;11:374-378.
29. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007;27;68:1002-1007.
30. Gundogdu B, Al-Lahham T, Kadlubar F, Spencer H, Rudnicki SA. Racial differences in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:114-118.
31. Wittie M, Nelson L, Usher S, Ward K, Benatar M. Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment. Neuroepidemiology 2013;40:133-141.